Evidence map›Paper›PMID 26030674›Full record

ArticleInternational journal of molecular sciences2015

Conformational ensembles explored dynamically from disordered peptides targeting chemokine receptor CXCR4.

Marian Vincenzi, Susan Costantini, Stefania Scala, Diego Tesauro, Antonella Accardo, Marilisa Leone, Giovanni Colonna, Jean Guillon, Luigi Portella, Anna Maria Trotta and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. The Ability of Chlorophyll to Trap Carcinogen Aflatoxin BInternational journal of molecular sciences · 2022
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Marian VincenziDepartment of Pharmacy University of Naples "Federico II", and CIRPeB, Via Mezzocannone 16, I-80134 Naples, Italy. marian.vincenzi@unina.it.
Susan CostantiniOncology Research Center of Mercogliano (CROM), Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, I-80131 Napoli, Italy. s.costantini@istitutotumori.na.it.
Stefania ScalaMolecular Immunology and Immuneregulation, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, I-80131 Napoli, Italy. s.scala@istitutotumori.na.it.
Diego TesauroDepartment of Pharmacy University of Naples "Federico II", and CIRPeB, Via Mezzocannone 16, I-80134 Naples, Italy. diego.tesauro@unina.it.
Antonella AccardoDepartment of Pharmacy University of Naples "Federico II", and CIRPeB, Via Mezzocannone 16, I-80134 Naples, Italy. antonella.accardo@unina.it.
Marilisa LeoneInstitute of Biostructures and Bioimaging (IBB), National Research Council (CNR), Via Mezzocannone 16, I-80134 Naples, Italy. marilisa.leone@cnr.it.
Giovanni ColonnaCenter of Medical Informatics, AOU, Second University of Naples, I-80138 Napoli, Italy. giovanni.colonna@unina2.it.
Jean GuillonUFR des Sciences Pharmaceutiques-Collège Sciences de la Santé, INSERM U869, Laboratoire ARNA, Université de Bordeaux, 146 rue Léo Saignat, 33076 Bordeaux cedex, France. jean.guillon@u-bordeaux.fr.
Luigi PortellaMolecular Immunology and Immuneregulation, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, I-80131 Napoli, Italy. portella@gmail.com.
Anna Maria TrottaMolecular Immunology and Immuneregulation, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, I-80131 Napoli, Italy. amt78@libero.it.
Luisa RongaUFR des Sciences Pharmaceutiques-Collège Sciences de la Santé, INSERM U869, Laboratoire ARNA, Université de Bordeaux, 146 rue Léo Saignat, 33076 Bordeaux cedex, France. luisa.ronga@u-bordeaux.fr.
Filomena RossiDepartment of Pharmacy University of Naples "Federico II", and CIRPeB, Via Mezzocannone 16, I-80134 Naples, Italy. filomena.rossi@unina.it.
Institute of Biostructure and Bioimaging · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITUniversité de Bordeaux · FRUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work reports on the design and the synthesis of two short linear peptides both containing a few amino acids with disorder propensity and an allylic ester group at the C-terminal end. Their structural properties were firstly analyzed by means of experimental techniques in solution such as CD and NMR methods that highlighted peptide flexibility. These results were further confirmed by MD simulations that demonstrated the ability of the peptides to assume conformational ensembles. They revealed a network of transient and dynamic H-bonds and interactions with water molecules. Binding assays with a well-known drug-target, i.e., the CXCR4 receptor, were also carried out in an attempt to verify their biological function and the possibility to use the assays to develop new specific targets for CXCR4. Moreover, our data indicate that these peptides represent useful tools for molecular recognition processes in which a flexible conformation is required in order to obtain an interaction with a specific target.

Indexed as

Circular DichroismHumansHydrogen BondingIntrinsically Disordered ProteinsMolecular Dynamics SimulationPeptidesProtein BindingProtein ConformationProtein FoldingProton Magnetic Resonance SpectroscopyReceptors, CXCR4CXCR4 protein, humanIntrinsically Disordered ProteinsPeptidesReceptors, CXCR4CDchemokineconformational ensembleintrinsically disordered protein (IDP)intrinsically disordered region (IDR)MDNMR

Identifiers

PMID26030674
PMCPMC4490436
OpenAlexW2150352107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.